These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 11378008

  • 1. The effects of enalapril-digoxin-diuretic combination therapy on nutritional and anthropometric indices in chronic congestive heart failure: preliminary findings in cardiac cachexia.
    Adigun AQ, Ajayi AA.
    Eur J Heart Fail; 2001 Jun; 3(3):359-63. PubMed ID: 11378008
    [Abstract] [Full Text] [Related]

  • 2. Anthropometric evaluation of cachexia in chronic congestive heart failure: the role of tricuspid regurgitation.
    Ajayi AA, Adigun AQ, Ojofeitimi EO, Yusuph H, Ajayi OE.
    Int J Cardiol; 1999 Sep 30; 71(1):79-84. PubMed ID: 10522568
    [Abstract] [Full Text] [Related]

  • 3. Tumor necrosis factor-alpha serum activity during treatment of acute decompensation of cachectic and non-cachectic patients with advanced congestive heart failure.
    Parissis JT, Venetsanou KF, Mentzikof DG, Ziras NG, Kefalas CG, Karas SM.
    Scand Cardiovasc J; 1999 Sep 30; 33(6):344-50. PubMed ID: 10622546
    [Abstract] [Full Text] [Related]

  • 4. Cardiac autonomic function in Blacks with congestive heart failure: vagomimetic action, alteration in sympathovagal balance, and the effect of ACE inhibition on central and peripheral vagal tone.
    Adigun AQ, Asiyanbola B, Ajayi AA.
    Cell Mol Biol (Noisy-le-grand); 2001 Sep 30; 47(6):1063-7. PubMed ID: 11785658
    [Abstract] [Full Text] [Related]

  • 5. Rationale and design of the third vasodilator-heart failure trial (V-HeFT III): felodipine as adjunctive therapy to enalapril and loop diuretics with or without digoxin in chronic congestive heart failure. V-HeFT III investigators.
    Boden WE, Ziesche S, Carson PE, Conrad CH, Syat D, Cohn JN.
    Am J Cardiol; 1996 May 15; 77(12):1078-82. PubMed ID: 8644661
    [Abstract] [Full Text] [Related]

  • 6. Impact of angiotensin-converting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failure.
    Luzier AB, Forrest A, Adelman M, Hawari FI, Schentag JJ, Izzo JL.
    Am J Cardiol; 1998 Aug 15; 82(4):465-9. PubMed ID: 9723634
    [Abstract] [Full Text] [Related]

  • 7. Congestive heart failure and ventricular arrhythmias in relation to serum magnesium.
    Oladapo OO, Falase AO.
    Afr J Med Med Sci; 2000 Aug 15; 29(3-4):265-8. PubMed ID: 11714003
    [Abstract] [Full Text] [Related]

  • 8. Adjunctive sympathoplegic therapy to ACE inhibition in Blacks with congestive heart failure: a comparison of alpha-1 with beta-1 blockade on exercise tolerance and cardiac sympathovagal reflex activity.
    Ajayi AA, Sofowora GG, Adigun AQ, Asiyanbola B.
    Ethn Dis; 2003 Aug 15; 13(1):71-9. PubMed ID: 12723015
    [Abstract] [Full Text] [Related]

  • 9. [Atrial natriuretic factor in patients with cardiac decompensation before and after chronic therapy with an angiotensin-converting enzyme inhibitor].
    Pomini G, Rugna A, Lupia M, Opocher G, Gribaldo R.
    G Ital Cardiol; 1992 Jul 15; 22(7):807-12. PubMed ID: 1473654
    [Abstract] [Full Text] [Related]

  • 10. Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group.
    Ettinger SJ, Benitz AM, Ericsson GF, Cifelli S, Jernigan AD, Longhofer SL, Trimboli W, Hanson PD.
    J Am Vet Med Assoc; 1998 Dec 01; 213(11):1573-7. PubMed ID: 9838955
    [Abstract] [Full Text] [Related]

  • 11. [Oral enalapril in patients with symptomatic ventricular septal defects].
    Vázquez-Antona CA, Simón Ruiz S, Rijlaarsdam M, Miranda Chávez I, Leiva JL, Buendía A, Attie F.
    Arch Inst Cardiol Mex; 1996 Dec 01; 66(6):496-504. PubMed ID: 9133310
    [Abstract] [Full Text] [Related]

  • 12. Community pharmacist outreach program directed at physicians treating congestive heart failure.
    Turner CJ, Parfrey P, Ryan K, Miller R, Brown A.
    Am J Health Syst Pharm; 2000 Apr 15; 57(8):747-52. PubMed ID: 10786260
    [Abstract] [Full Text] [Related]

  • 13. Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).
    Massie BM, Berk MR, Brozena SC, Elkayam U, Plehn JF, Kukin ML, Packer M, Murphy BE, Neuberg GW, Steingart RM.
    Circulation; 1993 Aug 15; 88(2):492-501. PubMed ID: 8339411
    [Abstract] [Full Text] [Related]

  • 14. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study.
    Packer M, Gheorghiade M, Young JB, Costantini PJ, Adams KF, Cody RJ, Smith LK, Van Voorhees L, Gourley LA, Jolly MK.
    N Engl J Med; 1993 Jul 01; 329(1):1-7. PubMed ID: 8505940
    [Abstract] [Full Text] [Related]

  • 15. Plasma concentration of Fas/Fas ligand and left ventricular function in response to metoprolol in conjunction with standard treatment.
    Hou YP, Wu JL, Fan Q, Liu MB, Yin BL, Zhang L.
    Clin Sci (Lond); 2007 Mar 01; 112(5):299-304. PubMed ID: 17020540
    [Abstract] [Full Text] [Related]

  • 16. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M, Takada M, Hirooka K, Isobe F, Yasumura Y.
    J Clin Pharm Ther; 2005 Dec 01; 30(6):603-10. PubMed ID: 16336294
    [Abstract] [Full Text] [Related]

  • 17. The effects of frusemide and angiotensin-converting enzyme inhibitors and their combination on cardiac and renal haemodynamics in heart failure.
    Cleland JG, Gillen G, Dargie HJ.
    Eur Heart J; 1988 Feb 01; 9(2):132-41. PubMed ID: 2832173
    [Abstract] [Full Text] [Related]

  • 18. Effect of digoxin noncompliance on hospitalization and mortality in patients with heart failure in long-term therapy: a prospective cohort study.
    Miura T, Kojima R, Mizutani M, Shiga Y, Takatsu F, Suzuki Y.
    Eur J Clin Pharmacol; 2001 Apr 01; 57(1):77-83. PubMed ID: 11372597
    [Abstract] [Full Text] [Related]

  • 19. Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with naturally acquired heart failure: results of the Invasive Multicenter PROspective Veterinary Evaluation of Enalapril study. The IMPROVE Study Group.
    J Vet Intern Med; 1995 Apr 01; 9(4):234-42. PubMed ID: 8523320
    [Abstract] [Full Text] [Related]

  • 20. Complications during enalapril and diuretic therapy for congestive cardiac failure.
    Mehta S, Vijayakumar M.
    Indian J Pediatr; 2009 Sep 01; 76(9):963-4. PubMed ID: 19904515
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.